Back to results
US 11,634,500 B2Granted
Anti-CD73 antibodies and compositions
AssigneeLes Laboratoires Servier
InventorsMichael Monrad Grandal, Torben Gjetting, Johan Lantto, Janus Schou Jakobsen, Randi Westh Hansen, Camilla Fröhlich
Life of this patent
Estimating the term…
Abstract
This invention relates to anti-CD73 antibodies and methods of using them in treating diseases and conditions related to CD73 activity, e.g., cancer.
Claims20
An anti-CD73 antibody or an antigen-binding portion thereof, wherein said antibody comprises the H-CDR1-3 and L-CDR1-3 amino acid sequences of:
- a) SEQ ID NOs:
- 17-22, respectively;
- b) SEQ ID NOs:
- 23-28, respectively;
- c) SEQ ID NOs:
- 29-34, respectively;
- or
- d) SEQ ID NOs:
- 35-40, respectively.
6 more elements
An anti-CD73 antibody that comprises:
- a) a heavy chain (HC) comprising the amino acid sequences of SEQ ID NOs:
- 9 and 41 and a light chain (LC) comprising the amino acid sequences of SEQ ID NOs:
- 13 and 42;
- b) an HC comprising the amino acid sequences of SEQ ID NOs:
- 10 and 41 and an LC comprising the amino acid sequences of SEQ ID NOs:
- 14 and 42;
- c) an HC comprising the amino acid sequences of SEQ ID NOs:
- 11 and 41 and an LC comprising the amino acid sequences of SEQ ID NOs:
- 15 and 42;
- or
- d) an HC comprising the amino acid sequences of SEQ ID NOs:
- 12 and 41 and an LC comprising the amino acid sequences of SEQ ID NOs:
- 16 and 42.
10 more elements
An anti-CD73 antibody that comprises a heavy chain (HC) comprising the amino acid sequences of SEQ ID NOs:
- 11 and 41 and a light chain (LC) comprising the amino acid sequences of SEQ ID NOs:
- 15 and 42.
Dependencies are inferred from the claim text.